STOCK TITAN

BioLife Solutions Updates Earnings Call Information

BioLife Solutions (NASDAQ: BLFS), a leading developer and supplier of cell processing tools and services for the cell and gene therapy (CGT) market, has provided updated dial-in information for their earnings call scheduled for today at 4:30pm ET.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

BioLife Solutions (NASDAQ: BLFS), a leading developer and supplier of cell processing tools and services for the cell and gene therapy (CGT) market, has provided updated dial-in information for their earnings call scheduled for today at 4:30pm ET. U.S. participants can dial 1-833-630-0431, while international callers should use 1-412-317-1808.

BioLife Solutions specializes in providing solutions that maintain the health and function of biological materials throughout the collection, development, manufacturing, and distribution processes, supporting the commercialization of new therapies in the CGT market.

Loading...
Loading translation...
Argus Session date unavailable
+4.16% session move Open Argus
Details

News Market Reaction – BLFS

The recorded move for BLFS in the trading session of this news was +4.16%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

BOTHELL, Wash., May 8, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the cell and gene therapy ("CGT") market, is announcing corrected call-in numbers for their Earnings Call this afternoon at 4:30pm ET. If you are joining, please use 1-833-630-0431 if calling from the United States or 1-412-317-1808 if dialing internationally.

About BioLife Solutions

BioLife is a leading developer and supplier of cell processing tools and services for the CGT market. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during the collection, development, manufacturing and distribution. For more information, please visit www.biolifesolutions.com, and follow BioLife on LinkedIn and X.

Media & Investor Relations

At the Company

Troy Wichterman
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com 

Investors

Alliance Advisors IR
Jody Cain
(310) 691-7100
jcain@allianceadvisors.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-updates-earnings-call-information-302450601.html

SOURCE BioLife Solutions, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is BioLife Solutions (BLFS) Q1 2025 earnings call?

BioLife Solutions' earnings call is scheduled for May 8, 2025, at 4:30pm ET.

What are the dial-in numbers for BioLife Solutions' earnings call?

For U.S. callers: 1-833-630-0431; for international callers: 1-412-317-1808.

What does BioLife Solutions (BLFS) do?

BioLife Solutions is a developer and supplier of cell processing tools and services for the cell and gene therapy market, providing solutions for maintaining biological materials during collection, development, manufacturing, and distribution.

Who is the CFO of BioLife Solutions (BLFS)?

Troy Wichterman serves as the Chief Financial Officer of BioLife Solutions.

Keep reading